Allergan plc (AGN) and Nature’s Sunshine Products Inc. (NASDAQ:NATR) Comparison side by side

As Drugs – Generic businesses, Allergan plc (NYSE:AGN) and Nature’s Sunshine Products Inc. (NASDAQ:NATR), are affected by compare. This especially applies to their dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation.

Valuation & Earnings

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Allergan plc 179 3.20 327.80M -21.63 0.00
Nature’s Sunshine Products Inc. 10 0.00 7.47M 0.02 475.26

Table 1 shows top-line revenue, earnings per share (EPS) and valuation of the two companies.


Table 2 shows the return on assets, return on equity and net margins of the two firms.

Net Margins Return on Equity Return on Assets
Allergan plc 182,740,550.79% -10.8% -7%
Nature’s Sunshine Products Inc. 77,650,727.65% 0.3% 0.2%

Volatility and Risk

Allergan plc’s 1.63 beta indicates that its volatility is 63.00% more volatile than that of S&P 500. Competitively, Nature’s Sunshine Products Inc.’s 31.00% volatility makes it less volatile than S&P 500, because of the 0.69 beta.


Allergan plc’s Current Ratio is 0.7 while its Quick Ratio is 0.6. On the competitive side is, Nature’s Sunshine Products Inc. which has a 1.7 Current Ratio and a 1 Quick Ratio. Nature’s Sunshine Products Inc. is better positioned to pay off short and long-term obligations compared to Allergan plc.

Analyst Recommendations

The following table given below contains the ratings and recommendations for Allergan plc and Nature’s Sunshine Products Inc.

Sell Ratings Hold Ratings Buy Ratings Rating Score
Allergan plc 0 3 1 2.25
Nature’s Sunshine Products Inc. 0 0 0 0.00

The consensus price target of Allergan plc is $175, with potential downside of -6.08%.

Institutional & Insider Ownership

The shares of both Allergan plc and Nature’s Sunshine Products Inc. are owned by institutional investors at 91.4% and 75.9% respectively. Insiders owned roughly 0.1% of Allergan plc’s shares. Comparatively, insiders own roughly 6.2% of Nature’s Sunshine Products Inc.’s shares.


Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Allergan plc -0.3% -4.19% 10.44% 11.54% -12.77% 20.08%
Nature’s Sunshine Products Inc. -1.85% -2.69% 0.11% 10.8% 10.8% 10.8%

For the past year Allergan plc was more bullish than Nature’s Sunshine Products Inc.


Allergan plc beats Nature’s Sunshine Products Inc. on 7 of the 12 factors.

Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Specialized Therapeutics, US General Medicine, and International segments. The company offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, womenÂ’s health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as AlzheimerÂ’s disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, the company distributes generic and branded pharmaceutical products primarily to independent and chain pharmacies, nursing homes, mail order pharmacies, hospitals, clinics, and physician offices. Further, it develops a portfolio of breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. The company has licensing agreement with Assembly Biosciences, Inc.; Mimetogen Pharmaceuticals, Inc.; Almirall, S.A; Naurex, Inc.; and Merck & Co. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.

NatureÂ’s Sunshine Products, Inc., together with its subsidiaries, primarily engages in the manufacture and direct sale of nutritional and personal care products worldwide. It operates through four segments: NSP Americas; NSP Russia, Central and Eastern Europe; Synergy WorldWide; and China and New Markets. The company offers general health line of assorted health products related to blood sugar support, bone health, cellular health, cognitive function, essential oils, joint health, mood, sexual health, sleep, sports and energy, and vision. It also provides immunity, cardiovascular, and digestive products; and personal care products, including oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment products, toothpastes, and skin cleansers, as well as weight management products. The company offers its products under the NatureÂ’s Sunshine Products and Synergy WorldWide brands through a sales force of independent managers and distributors. NatureÂ’s Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.